Advertisement

Topics

Quanterix to Showcase New SR-X Ultra-Sensitive Biomarker Detection System™ at Neuroscience 2017

14:49 EST 10 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
New technology unlocks ultra-sensitive biomarker detection with the potential to advance the diagnosis and treatment of neurological diseases Quanterix Corporation, a company digitizing biomarker analysis with the goal ...

Other Sources for this Article

PAN Communications
Lauren Kaufman, 617-502-4300
quanterix@pancomm.com

NEXT ARTICLE

More From BioPortfolio on "Quanterix to Showcase New SR-X Ultra-Sensitive Biomarker Detection System™ at Neuroscience 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...